General Ophthalmology - Eye Health Academy

33-48 of 81

OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
Eye on Ocular Health
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
- Marlene Mimi Maeusli, PhD.
Myopia Control in Europe: The Case for Upfront Investment in Childhood
Myopia Control in Europe: The Case for Upfront Investment in Childhood
Eye on Ocular Health
Myopia Control in Europe: The Case for Upfront Investment in Childhood
Combination Therapy Slows Myopia Progression in Children with Premyopia
Combination Therapy Slows Myopia Progression in Children with Premyopia
Eye on Ocular Health
Combination Therapy Slows Myopia Progression in Children with Premyopia
Tackling the Myopia Epidemic: Causes, Consequences, and Opportunities for Prevention
Tackling the Myopia Epidemic: Causes, Consequences, and Opportunities for Prevention
Eye on Ocular Health
Tackling the Myopia Epidemic: Causes, Consequences, and Opportunities for Prevention
- Ryan Quigley
- Michael D. Twa, OD, PhD, FAAO
- David A. Berntsen, OD, PhD, FAAO
Advancing Myopia Detection and Treatment: A Look at Novel Innovations
Advancing Myopia Detection and Treatment: A Look at Novel Innovations
Eye on Ocular Health
Advancing Myopia Detection and Treatment: A Look at Novel Innovations
- Ryan Quigley
- Michael D. Twa, OD, PhD, FAAO
- David A. Berntsen, OD, PhD, FAAO
Anti-VEGF Use in Retinal Vein Occlusion: Insights from a Real-World Cohort
Anti-VEGF Use in Retinal Vein Occlusion: Insights from a Real-World Cohort
Eye on Ocular Health
Anti-VEGF Use in Retinal Vein Occlusion: Insights from a Real-World Cohort
Growing Comfortable with the Suprachoroidal Space
Growing Comfortable with the Suprachoroidal Space
Clinical Minute Retina
Growing Comfortable with the Suprachoroidal Space
- Maria H. Berrocal, MD
- Robert Avery, MD
Update on Predatory "Cell Therapy" Clinics
Update on Predatory "Cell Therapy" Clinics
Clinical Minute Retina
Update on Predatory "Cell Therapy" Clinics
- Maria H. Berrocal, MD
- Ajay E. Kuriyan, MD, MS
Is Teleretinal Screening for DR and DME Effective?
Is Teleretinal Screening for DR and DME Effective?
Clinical Minute Retina
Is Teleretinal Screening for DR and DME Effective?
- Maria H. Berrocal, MD
- Christina Y. Weng, MD, MBA, FASRS
Switch Case: 66-Year-Old Man With Wet AMD
Switch Case: 66-Year-Old Man With Wet AMD
AMD/DME Case Files: Real-World Patient Profiles
Switch Case: 66-Year-Old Man With Wet AMD
- Priya Vakharia, MD
Potential Switch Case: 81-Year-Old Man With Wet AMD
Potential Switch Case: 81-Year-Old Man With Wet AMD
AMD/DME Case Files: Real-World Patient Profiles
Potential Switch Case: 81-Year-Old Man With Wet AMD
- Priya Vakharia, MD
Switch Case: Massive PED (Part 1)
Switch Case: Massive PED (Part 1)
AMD/DME Case Files: Real-World Patient Profiles
Switch Case: Massive PED (Part 1)
- Yasha S. Modi, MD, MHS
Switch Case: Massive PED (Part 2)
Switch Case: Massive PED (Part 2)
AMD/DME Case Files: Real-World Patient Profiles
Switch Case: Massive PED (Part 2)
- Yasha S. Modi, MD, MHS
Switch Case: Bilateral DME and Years of Continuous Anti-VEGF Treatment
Switch Case: Bilateral DME and Years of Continuous Anti-VEGF Treatment
AMD/DME Case Files: Real-World Patient Profiles
Switch Case: Bilateral DME and Years of Continuous Anti-VEGF Treatment
- Joseph M. Coney, MD
Treatment-Naïve Case: DME in a 54-Year-Old-Patient With Undiagnosed Diabetes
Treatment-Naïve Case: DME in a 54-Year-Old-Patient With Undiagnosed Diabetes
AMD/DME Case Files: Real-World Patient Profiles
Treatment-Naïve Case: DME in a 54-Year-Old-Patient With Undiagnosed Diabetes
- Joseph M. Coney, MD
Roundtable: When and How to Approach Using Newly Approved Anti-VEGF Agents
Roundtable: When and How to Approach Using Newly Approved Anti-VEGF Agents
AMD/DME Case Files: Real-World Patient Profiles
Roundtable: When and How to Approach Using Newly Approved Anti-VEGF Agents
- Priya Vakharia, MD
- Joseph M. Coney, MD
- Yasha S. Modi, MD, MHS

3/6